Verrica Pharmaceuticals (VRCA) Earnings Date, Estimates & Call Transcripts → The Best AI Stock to Own in the World Today is Trading for Just $25 (From Banyan Hill Publishing) (Ad) Free VRCA Stock Alerts $6.79 -0.06 (-0.88%) (As of 04/24/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Earnings SummaryUpcoming Earnings DateMay. 14EstimatedActual EPS (Feb. 29) -$0.48 Missed By -$0.01 Consensus EPS (Feb. 29) -$0.47 Read Call TranscriptListen to Call Get Verrica Pharmaceuticals Earnings AlertsEnter your email address below to receive the latest news and earnings results for VRCA and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueVRCA Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.VRCA Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Crypto Swap ProfitsHe Is Giving Away BitcoinAnd my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.>> Register right here Verrica Pharmaceuticals Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20241($0.43)($0.43)($0.43)Q2 20241($0.39)($0.39)($0.39)Q3 20241($0.35)($0.35)($0.35)Q4 20241($0.29)($0.29)($0.29)FY 20244($1.46)($1.46)($1.46)VRCA Earnings Date and InformationVerrica Pharmaceuticals last released its quarterly earnings results on February 29th, 2024. The reported ($0.48) EPS for the quarter, missing the consensus estimate of ($0.47) by $0.01. The firm earned $1.99 million during the quarter, compared to analysts' expectations of $1.10 million. Verrica Pharmaceuticals has generated ($1.46) earnings per share over the last year (($1.46) diluted earnings per share). Earnings for Verrica Pharmaceuticals are expected to grow in the coming year, from ($1.59) to ($0.63) per share. Verrica Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 14th, 2024 based off prior year's report dates.Read More Verrica Pharmaceuticals Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 5/14/2024Estimated)------- 2/29/2024Q4 2023($0.47)($0.48)($0.01)($0.43)$1.10 million$1.99 million 11/9/2023Q3 2023($0.22)($0.32)($0.10)($0.10)$1.12 million$2.92 million8/8/2023Q2 2023($0.22)($0.24)($0.02)($0.24)-$0.18 million5/9/2023Q1 2023($0.20)($0.15)+$0.05($0.15)-$0.04 million3/6/2023Q4 2022($0.19)($0.14)+$0.05($0.14)-$0.07 million11/7/2022Q3 2022($0.11)$0.03+$0.14$0.06$8.00 million$8.32 million Get the Latest News and Ratings for VRCA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Verrica Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 8/11/2022Q2 2022($0.36)($0.36)-($0.35)-$0.21 million5/9/2022Q1 2022($0.59)($0.30)+$0.29($0.29)-$0.43 million3/2/2022Q4 2021($0.48)($0.35)+$0.13($0.35)--11/12/2021Q3 2021($0.51)($0.47)+$0.04($0.45)--8/10/2021Q2 2021($0.41)($0.43)($0.02)($0.43)--5/7/2021Q1 2021($0.35)($0.04)+$0.31($0.04)-$12.00 million Verrica Pharmaceuticals Earnings - Frequently Asked Questions When is Verrica Pharmaceuticals's earnings date? Verrica Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 14th, 2024 based off last year's report dates. Learn more on VRCA's earnings history. Did Verrica Pharmaceuticals beat their earnings estimates last quarter? In the previous quarter, Verrica Pharmaceuticals (NASDAQ:VRCA) missed the analysts' consensus estimate of ($0.47) by $0.01 with a reported earnings per share (EPS) of ($0.48). Learn more on analysts' earnings estimate vs. VRCA's actual earnings. How can I listen to Verrica Pharmaceuticals's earnings conference call? The conference call for Verrica Pharmaceuticals's latest earnings report can be listened to online. Listen to Conference Call How can I read Verrica Pharmaceuticals's conference call transcript? The conference call transcript for Verrica Pharmaceuticals's latest earnings report can be read online. Read Transcript How much revenue does Verrica Pharmaceuticals generate each year? Verrica Pharmaceuticals (NASDAQ:VRCA) has a recorded annual revenue of $5.12 million. How much profit does Verrica Pharmaceuticals generate each year? Verrica Pharmaceuticals (NASDAQ:VRCA) has a recorded net income of -$67 million. VRCA has generated -$1.46 earnings per share over the last four quarters. What is Verrica Pharmaceuticals's EPS forecast for next year? Verrica Pharmaceuticals's earnings are expected to grow from ($1.59) per share to ($0.63) per share in the next year. More Earnings Resources from MarketBeat Related Companies: CRMD Earnings Results INZY Earnings Results AKBA Earnings Results ERAS Earnings Results TERN Earnings Results XOMA Earnings Results RAPT Earnings Results AQST Earnings Results KMDA Earnings Results AVIR Earnings Results Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: GE Aerospace is Ready for Liftoff After Strong EarningsTaiwan Semiconductor Earnings: AI Dominance and Future OutlookCSX Co.: The Railroad Powering Ahead with an Earnings Beat What's Driving Tesla Lower Ahead of its Earnings?Blackrock vs. State Street: Earnings in a Volatile MarketWhat to Expect From the Q1 Earnings Reporting SeasonLululemon Stock Implodes Post Earnings, Guidance Muted This page (NASDAQ:VRCA) was last updated on 4/24/2024 by MarketBeat.com Staff From Our PartnersHe Is Giving Away BitcoinCrypto Swap Profitstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsThe #1 Biotech Stock to Have on Your Radar in 2024… Huge AlertsFed launches fourth dollar overhaulStansberry ResearchThe #1 Crypto for 2024InvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Verrica Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
